Patient P-03105

Synthetic patientONX-7 · Day 129 · 35–44 · M · baseline S12Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

31%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S12
Day 80 AD-05 recommended — Adherence Support AD-05
Day 81 Patient accepted — Started AD-05 in the companion
Day 86 No meaningful change — Adherence Support AD-05

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+14
Nutritional resilience-13
Inflammatory activity+7
Treatment adherence-5

What helped?

Adherence Support AD-05Day 80
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

5.7/10

improving · +0.4 vs previous 14 d

Stress level

Daily log

4.3/10

worsening · +0.3 vs previous 14 d

Pessimism score

Daily log

3.6/10

stable · +0.0 vs previous 14 d

Sleep quality

Wearable

61.1/100

stable · -0.0 vs previous 14 d

Libido

Daily log

5.1/10

stable · +0.0 vs previous 14 d

HRV

Wearable

50.4 ms

stable · +1.7 vs previous 14 d

Toxicity

Blood

21.1/100

improving · -4.0 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 72 from the failing basin, 20 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.2 next day on high-intake days · n 20

Would not help

AD-05 Adherence Support
already tried, no meaningful change
Keep lactose low
GI +3.7 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-5.2supporter · 95%
Lactose
+3.7detractor · 92%
Histamine load
+0.6no signal · 15%
Caffeine
-0.5no signal · 15%
Dietary fat load
+0.2no signal · 15%
Alcohol
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.8 · butyrate capacity 56/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 48 ms
Sleep: 7.2 h
Steps: 9,483
Resting HR: 60 bpm

Daily log: GI score 20, nutritional resilience 63, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03482	44%	S05	AD-05	no change	67
P-03204	38%	S16	AD-05	improved	48
P-03424	37%	S12	AD-05	improved	41
P-03111	36%	S07	AD-05	no change	48
P-03187	34%	S12	AD-05	no change	80
P-03351	34%	S07	AD-05	no change	51
P-03369	32%	S18	AD-05	no change	37
P-03380	32%	S16	AD-05	improved	34
P-03034	30%	S14	AD-05	no change	30
P-03122	30%	S13	AD-05	no change	40
P-03129	30%	S18	AD-05	no change	32
P-03441	30%	S19	AD-05	improved	37